Related Experiment Video
Updated: Jun 30, 2026

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
Molecular mechanisms of diabetic heart disease: Insights from transcriptomic technologies
Marcella Conning-Rowland1, Richard M Cubbon1
1Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Insights
Diabetes mellitus (DM) significantly increases heart failure risk. This review highlights altered fatty acid metabolism and inflammation in the heart as key factors, suggesting new therapeutic targets for diabetic heart disease.
Area of Science:
- Cardiovascular Research
- Metabolic Disease
- Molecular Biology
Background:
- Diabetes mellitus (DM) affects over 500 million adults globally.
- DM doubles the risk of major cardiovascular events and specifically elevates heart failure risk, independent of other conditions.
- Endothelial cell (EC) dysfunction, a hallmark of DM, contributes to cardiac complications.
Purpose of the Study:
- To systematically review 'omics' studies identifying molecular drivers of cardiac dysfunction in DM.
- To elucidate the extent to which EC dysfunction and other factors contribute to DM-associated heart failure.
- To identify novel therapeutic targets for diabetic heart disease.
Main Methods:
- Systematic review of transcriptomics studies on the myocardium and cardiac ECs in DM.
- Analysis of 'omics' data to identify common molecular themes.
- Synthesis of findings to pinpoint key pathological processes.
Main Results:
- Common themes identified include significant alterations in myocardial fatty acid metabolism.
- Increased inflammation within the myocardium is a recurring finding in DM.
- These molecular changes are linked to myocardial dysfunction and heart failure.
Conclusions:
- Altered fatty acid metabolism and inflammation are key molecular processes underlying heart failure in diabetes mellitus.
- Further research is needed to validate these factors as causal and prioritize them for therapeutic development.
- Targeting these pathways may offer novel treatment strategies for diabetic cardiomyopathy.
Abstract:
Over half a billion adults across the world have diabetes mellitus (DM). This has a wide-ranging impact on their health, including more than doubling their risk of major cardiovascular events, in comparison to age-sex matched individuals without DM. Notably, the risk of heart failure is particularly increased, even when coronary artery disease and hypertension are not present. Macro- and micro-vascular complications related to endothelial cell (EC) dysfunction are a systemic feature of DM and can affect the heart. However, it remains unclear to what extent these and other factors underpin myocardial dysfunction and heart failure linked with DM. Use of unbiased 'omics approaches to profile the molecular environment of the heart offers an opportunity to identify novel drivers of cardiac dysfunction in DM. Multiple transcriptomics studies have characterised the whole myocardium or isolated cardiac ECs. We present a systematic summary of relevant studies, which identifies common themes including alterations in both myocardial fatty acid metabolism and inflammation. These findings prompt further research focussed on these processes to validate potentially causal factors for prioritisation into therapeutic development pipelines.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Heart Failure II: Pathophysiology
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Diabetic Nephropathy

